𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BCHEandCYP2D6genetic variation in Alzheimer’s disease patients treated with cholinesterase inhibitors

✍ Scribed by Caterina Chianella; Daniela Gragnaniello; Pierpaolo Maisano Delser; Maria Francesca Visentini; Elisabetta Sette; Maria Rosaria Tola; Guido Barbujani; Silvia Fuselli

Publisher
Springer
Year
2011
Tongue
English
Weight
281 KB
Volume
67
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of cognitive rehabilitation in
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors
✍ Luca Rozzini; Daniela Costardi; Barbara Vicini Chilovi; Simone Franzoni; Marco T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract ## Background Individuals who have Mild Cognitive Impairment (MCI) may be in a transitional stage between aging and Alzheimer's disease (AD). The high rate of conversion from MCI to AD makes early treatment an important clinical issue. Recent evidence suggests that cognitive training i

The efficacy of galantamine in the treat
The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure
✍ J. E. Mintzer; P. Kershaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 2 views

## Abstract ## Background Acetylcholinesterase inhibitors (AChEIs) can provide benefits at the cognitive, behavioral, and functional levels to patients with Alzheimer's disease (AD). With more AChEIs now available, treatment considerations may include whether the patient has had prior exposure to